Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis

Amyloid

Volumn 8, Issue 3, 2001, Pages 202-214

  Dezutter, N A ^a   Landman, W J M ^a   Jager, P L ^a   De Groot, T J ^a   Dupont, P J ^a   Tooten, P C J ^a   Zekarias, B ^a   Gruys, E ^a   Verbruggen, A M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Amyloid; Chrysamine G; Congo red; In vivo probe; SPECT; Technetium 99m, 123I SAP

Indexed keywords

CONGO RED; IODINE 123; SERUM AMYLOID P; TECHNETIUM 99M; TECHNETIUM MONOAMINEMONOAMIDEBISTHIOL CHRYSAMINE G TC 99M; UNCLASSIFIED DRUG; 99MTC MAMA CHRYSAMINE G; 99MTC-MAMA-CHRYSAMINE G; AMYLOID; BENZOIC ACID DERIVATIVE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; TECHNETIUM COMPLEX;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ARTHROPATHY; ARTICLE; AUTORADIOGRAPHY; DIAGNOSTIC ACCURACY; ENTEROCOCCUS FAECALIS; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; SCINTISCANNING; ANIMAL; CHEMISTRY; CHICKEN; COMPARATIVE STUDY; DISEASE MODEL; EVALUATION; FEMALE; METHODOLOGY; MICROBIOLOGY; MOLECULAR PROBE; PATHOGENICITY;

AMYLOID; AMYLOIDOSIS; ANIMALS; AUTORADIOGRAPHY; BENZOATES; CHICKENS; DISEASE MODELS, ANIMAL; ENTEROCOCCUS FAECALIS; EVALUATION STUDIES; FEMALE; IODINE RADIOISOTOPES; MOLECULAR PROBES; ORGANOTECHNETIUM COMPOUNDS; SERUM AMYLOID P-COMPONENT;

EID: 0034741147     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120109007363     Document Type: Article

References (67)

1. Alzheimer's disease: Initial report of the purification and characterisation of a novel cerebrovascular amyloid protein
2. Alzheimer's disease: Its proteins and genes
3. Peptide compositions of cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease
4. Islet amyloid, islet amyloid polypeptide, and diabetes mellitus
5. Amyloid fibril toxicity in Alzheimer's disease and diabetes
6. A new form of amyloid protein associated with chronic haemodialysis was identified as beta-2 microglobulin
7. Beta-2 microglobulin is an amyloidogenic protein in man
8. Dialysis associated amyloidosis
9. Unique amyloid subunit common to different types of amyloid fibril
10. Amino acid sequence of amyloid-related apoprotein (apo SAA1) from human high-density lipoprotein
11. The amino acid sequence of a major non-immunoglobulin component of some amyloid fibrils
12. Identification of amyloid A protein in a sporadic Muckle-Wells syndrome. N-terminal amino acid sequence after isolation from formalin fixed tissue
13. Characterisation of amyloid fibril proteins from medullary carcinoma of the thyroid
14. Amyloid fibril protein related to pre-albumin familial amyloidotic polyneuropathy
15. Identification of amyloid pre-albumin variant in familial amyloidotic polyneuropathy (Japanese type)
16. Amyloid fibril protein in familial amyloidotic polyneuropathy (Portuguese type): Definition of molecular abnormality in transthyretin (prealbumin)
17. Variant apolipoprotein A1 as a major constituent of a human hereditary amyloid
18. Purification and structural studies of a major Scrapie prion protein
19. Western blot mapping of disease-specific amyloid in various animal species and humans with transmissible spongiform encephalopathies using a high-yield purification method
20. Prp 27-30 is a normal soluble prion protein fragment released by human platelets
21. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome
22. On the binding of Congo red by amyloid
23. Ein spezifische amyloid-farbung mit Kongorot
24. Nomenclature of amyloid and amyloidosis-WHO-IUIS nomenclature subcommittee
25. The classification of amyloid deposits in clinicopathological practice
26. Diagnosis and monitoring of amyloidosis
27. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis
28. Amyloidosis
29. High-sensitivity diagnosis of AA amyloidosis using Congo red and immunohistochemistry detects missed amyloid deposits
30. Clinical benefits of diagnosing incipient AA amyloidosis in pediatric rheumatic diseases as estimated from a retrospective study
31. Generalized AA-amyloidosis in Siberian tigers (Panthera tigris altaica) with predominant renal medullary amyloid deposition
32. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure
33. Binding of serum amyloid-P component (SAP) by amyloid fibrils
34. 123I-labelled serum amyloid P component
35. Imaging amyloidosis with radiolabelled SAP
36. Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component
37. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: From diagnosis to prognosis
38. 131I-beta-2-microglobulin
39. 2-microglobulin amyloidosis
40. 2-Microglobulin-derived amyloidosis: Clinical use of scintigraphy and insights into its pathogenesis
41. 2-microglobulin
42. Production of recombinant human beta2-microglobulin for scintigraphic diagnosis of amyloidosis in uremia and hemodialysis
43. Utility of technetium Tc-99m pyrophosphate bone scanning in cardiac amyloidosis
44. 99mTc-pyrophosphate in amyloidosis
45. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localisation of bone seeking radiopharmaceuticals
46. A new imaging agent for medullary carcinoma of the thyroid
47. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis
48. Technetium-99m (V) DMSA uptake in amyloidosis
49. Demonstration of plasma proteinase inhibitors in beta-2-microglobulin amyloid deposits
50. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin
51. 99mTc-aprotinin
52. Anaphylactic reaction to aprotinin despite negative ocular sensitivity test
53. 2 conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer's disease
54. Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease
55. 99mTc-MAMA-chrysamine G derivatives for the diagnosis of Alzheimer's disease (AD)
56. 99mTc-MAMA-chrysamine G, a potential probe for beta-amyloid protein of Alzheimer's disease
57. A syndrome associated with growth depression and amyloid arthropathy in layers: A preliminary report
58. The role of various agents in chicken amyloid arthropathy
59. Chicken joint amyloid protein is of the AA type: I. Characterization of the amyloid protein
60. Induction of amyloid arthropathy in chickens
61. An improved Congo red method for amyloid
62. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value
63. Isolation of human C-reactive protein and serum amyloid P component
64. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose
65. Physiological properties and cellular and chemical constituents of blood
66. Light microscopic, immunohistochemical, and electron microscopic features of amyloid arthropathy in chickens
67. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression